Docetaxel combined with silver nanoparticles for synergistic therapy of prostate cancer via effectively inhibiting cell proliferation and inducing apoptosis
Yanzhong Zhao(Space Engineering University), Bin Liu(ETH Zurich), Hao Zhang(Northwestern Polytechnical University), Zhi Li, Zichang Lin(Central South University), Binlong Chen(Xichang University), Leye He(Central South University), Jialong Fan(Hunan University)
Cited by 2
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273